DJ Gilead Sciences Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 1.29% to $135.87 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.24% to 7,109.14 and Dow Jones Industrial Average falling 0.01% to 49,442.56.
This was the stock's fourth consecutive day of losses.
Gilead Sciences Inc. closed 13.62% short of its 52-week high of $157.29, which the company achieved on February 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.49% to $230.69, Pfizer Inc. $(PFE)$ fell 0.15% to $27.52, and Abbott Laboratories $(ABT)$ fell 0.84% to $96.00.
Trading volume (3.9 M) remained 2.7 million below its 50-day average volume of 6.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 20, 2026 16:36 ET (20:36 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments